Related Experiment Video

Updated: Jul 12, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

[Catecholamines in migraine and other paroxysmal conditions in children]

T A Lazebnik, S V Zozuliakova, L G Zalkind

    Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
    |January 1, 1991
    PubMed

    Insights

    Children with migraine showed altered adrenaline and noradrenaline excretion, differing from those with epilepsy or syncopes. These catecholamine changes may aid in diagnosing paroxysmal crises in vegetovascular dystonia.

    Area of Science:

    • Pediatric Neurology
    • Endocrinology
    • Clinical Chemistry

    Background:

    • Migraine, epilepsy, and syncopes are common paroxysmal conditions in children.
    • Diurnal catecholamine excretion patterns are not well-established for these pediatric conditions.
    • Vegetovascular dystonia is often associated with these paroxysmal events.

    Purpose of the Study:

    • To investigate the diurnal excretion patterns of adrenaline and noradrenaline in children with migraine, epilepsy, and syncopes.
    • To compare these excretion patterns with healthy controls.
    • To determine if catecholamine levels can aid in diagnosing paroxysmal crises.

    Main Methods:

    • Study included children aged 7-14 years with migraine (n=33), epilepsy (n=21), and syncopes (n=13).
    • Diurnal urine excretion of adrenaline and noradrenaline was measured using fluorometry.
    • Data were compared between patient groups and with control data.

    Main Results:

    • Children with epilepsy and syncopes showed reduced adrenaline excretion; noradrenaline levels were similar to controls.
    • Migraine patients exhibited significantly lower adrenaline and higher noradrenaline excretion.
    • The ratio of adrenaline to noradrenaline was significantly altered in migraine patients.

    Conclusions:

    • Altered adrenaline and noradrenaline excretion patterns are observed in children with migraine.
    • Changes in catecholamine excretion may serve as an additional diagnostic criterion for paroxysmal crises in vegetovascular dystonia.
    • Further research is warranted to elucidate the role of catecholamines in these pediatric neurological conditions.

    More Related Videos

    Investigating Migraine-Like Behavior Using Light Aversion in Mice05:23

    Investigating Migraine-Like Behavior Using Light Aversion in Mice

    Published on: August 11, 2021

    An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies05:49

    An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

    Published on: November 1, 2024

    Related Concept Videos

    Adrenergic Agonists: Therapeutic Classification01:18

    Adrenergic Agonists: Therapeutic Classification

    Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
    Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
    Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
    Adrenergic Agonists: Therapeutic Uses01:30

    Adrenergic Agonists: Therapeutic Uses

    Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
    Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
    Allergies and anaphylaxis:...
    Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

    Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

    β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
    Adrenal Gland Disorders01:27

    Adrenal Gland Disorders

    Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
    Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
    Dysrhythmias II: Classification of Tachyarrhythmias01:28

    Dysrhythmias II: Classification of Tachyarrhythmias

    Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.